PAZOPANIB

Description

Pazopanib – Targeted Therapy for Cancer Treatment

Overview

Pazopanib is a prescription oral medication classified as a tyrosine kinase inhibitor (TKI). It works by blocking certain proteins that support tumor growth and blood vessel formation, making it an effective targeted therapy for specific types of cancer. Pazopanib is commonly used in the treatment of advanced renal cell carcinoma (RCC) and soft tissue sarcoma (STS), offering patients an effective option to manage disease progression.

Key Features / Indications

• Active Ingredient: Pazopanib
• Therapeutic Class: Tyrosine kinase inhibitor (TKI)
• Indications:

o Advanced renal cell carcinoma (RCC)

o Advanced soft tissue sarcoma (STS) in patients who have received prior chemotherapy

• Administration: Oral, once daily
• Mechanism of Action: Inhibits vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), and c-Kit, reducing tumor angiogenesis and growth
• Benefits:

o Targeted therapy for specific cancers

o Convenient oral administration

o Slows tumor progression and helps manage symptoms

Why Choose Oncomed Pharmacy?

At Oncomed Pharmacy, we prioritize your health and convenience. We provide high-quality, authentic oncology medications, including Pazopanib, with prompt delivery and professional guidance. Our experienced pharmacists are available to answer questions, ensure safe administration, and support patients throughout their cancer treatment journey. Choosing Oncomed Pharmacy ensures access to trusted medications with exceptional customer care.

Uses of Medicine

Pazopanib is used primarily for:

• Treating advanced renal cell carcinoma (RCC)
• Managing advanced soft tissue sarcomas (STS)
• Slowing cancer progression in patients with previously treated cancers
• Supporting targeted therapy regimens as part of oncology treatment plans